Title |
In vivo effect of statins on the expression of the HIV co-receptors CCR5 and CXCR4
|
---|---|
Published in |
AIDS Research and Therapy, May 2013
|
DOI | 10.1186/1742-6405-10-10 |
Pubmed ID | |
Authors |
Edwin A Higuita, Fabián A Jaimes, Maria T Rugeles, Carlos J Montoya |
Abstract |
During the HIV-1 replication cycle, several molecules including chemokine receptors and cholesterol are crucial, and are therefore potential targets for therapeutic intervention. Indeed statins, compounds that inhibit cellular synthesis of cholesterol and have anti-inflammatory and immunomodulatory properties were shown to inhibit HIV-1 infection by R5 tropic strains but not by X4 strains in vitro, mainly by altering the chemokine receptor/ligands axes. Therefore, the objective of this study was to characterize in vivo, the capacity of statins to modulate in HIV seronegative and chronically HIV-1-infected adults the expression of CCR5 and CXCR4, of their ligands and the tropism of circulating HIV-1 strains. |
X Demographics
Geographical breakdown
Country | Count | As % |
---|---|---|
Canada | 1 | 20% |
United States | 1 | 20% |
United Kingdom | 1 | 20% |
Unknown | 2 | 40% |
Demographic breakdown
Type | Count | As % |
---|---|---|
Members of the public | 5 | 100% |
Mendeley readers
Geographical breakdown
Country | Count | As % |
---|---|---|
Australia | 1 | 3% |
Unknown | 34 | 97% |
Demographic breakdown
Readers by professional status | Count | As % |
---|---|---|
Researcher | 5 | 14% |
Student > Ph. D. Student | 4 | 11% |
Student > Doctoral Student | 4 | 11% |
Student > Master | 4 | 11% |
Professor | 3 | 9% |
Other | 8 | 23% |
Unknown | 7 | 20% |
Readers by discipline | Count | As % |
---|---|---|
Medicine and Dentistry | 11 | 31% |
Pharmacology, Toxicology and Pharmaceutical Science | 3 | 9% |
Biochemistry, Genetics and Molecular Biology | 3 | 9% |
Immunology and Microbiology | 3 | 9% |
Nursing and Health Professions | 1 | 3% |
Other | 5 | 14% |
Unknown | 9 | 26% |